Gerstein Fisher’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$630K Sell
7,847
-700
-8% -$56K 0.08% 213
2016
Q2
$673K Buy
8,547
+329
+4% +$24.8K 0.09% 189
2016
Q1
$592K Sell
8,218
-645
-7% -$48.8K 0.08% 200
2015
Q4
$747K Buy
8,863
+212
+2% +$17.6K 0.1% 173
2015
Q3
$724K Buy
8,651
+457
+6% +$38.6K 0.11% 165
2015
Q2
$684K Buy
8,194
+925
+13% +$70.5K 0.11% 185
2015
Q1
$528K Buy
7,269
+131
+2% +$9.33K 0.09% 221
2014
Q4
$492K Sell
7,138
-45
-0.6% -$3.04K 0.08% 222
2014
Q3
$466K Buy
7,183
+1,625
+29% +$103K 0.08% 216
2014
Q2
$346K Sell
5,558
-982
-15% -$58.6K 0.07% 231
2014
Q1
$385K Sell
6,540
-8,554
-57% -$477K 0.08% 209
2013
Q4
$770K Buy
15,094
+7,258
+93% +$363K 0.03% 326
2013
Q3
$394K Sell
7,836
-126
-2% -$6.6K 0.09% 215
2013
Q2
$391K Buy
+7,962
New +$433K 0.09% 189

Other funds holding LLY

Gerstein Fisher's LLY Position: Q3 2016 in Review

Gerstein Fisher reduced its Eli Lilly (LLY) stake by 8.2% in Q3 2016, selling an estimated $56K and leaving 7,847 shares worth $630K. The position accounts for 0.08% of the portfolio, ranked #213.

Gerstein Fisher first reported a position in LLY in Q2 2013 and has held it in 14 quarters since. The position peaked at $770K in Q4 2013. 1,177 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • Gerstein Fisher held 7,847 shares of Eli Lilly worth $630K as of Q3 2016.
  • Gerstein Fisher sold 700 Eli Lilly shares in Q3 2016, an estimated $56K.
  • Eli Lilly made up 0.08% of Gerstein Fisher's portfolio in Q3 2016, its #213 holding.
  • Gerstein Fisher first reported a position in Eli Lilly in Q2 2013 and has held it in 14 quarters since.
  • Gerstein Fisher's Eli Lilly position peaked at $770K in Q4 2013.
  • 1,177 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.